Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uritos vs Urotol for Overactive Bladder
NCT03575702Phase 3Completed
- Sponsor
- R-Pharm
- Start
- Jul 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imidafenacin in overactive bladder (OAB), sponsored by R-Pharm. Started Jul 2016; status: completed.
02
Drugs
imidafenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03575702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575702.